Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 22:16:39 - browse：6894

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Harvard's David Sinclair gets blowback over aging

entertainment

WSS

The history of OxyContin, told through Purdue Pharma documents

Large hospital system sues Multiplan for low

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Readout Newsletter: BridgeBio, Akero, and human embryo models

Where are patients getting their prescriptions for GLP

After John Oliver segment, STAT readers share their opioid

focus

Wikipedia

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

IVF doctors demand details after CooperSurgical lawsuit

State Dept. review finds Biden bears some blame for Afghanistan failures

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Moonlake's readout produced a cash windfall. Risks remain

After John Oliver segment, STAT readers share their opioid

BioMarin wins approval for gene therapy to treat hemophilia A

Families look for replacement for GSK asthma drug Flovent

Tori Bowie and the unacceptable rates of Black maternal death

Medicare drug price negotiation hearing pits pharma v Biden admin

leisure time

After John Oliver segment, STAT readers share their opioid

Timeline: Special counsel's investigation into Trump's handling of classified documents

Who are the detained American citizens released from prison in Iran?

Newly revealed memo details efforts to keep Trump in power following election loss

Florida health officials providing scant details on measles cases

Some of the ways extreme heat will change life as we know it

entertainment

explore

explore

knowledge